Medication

Genentech takes on BMS -- Merck with positive I/O lung cancer PhIII data

Genentech takes on BMS — Merck with positive I/O lung cancer PhIII data

Genentech takes on BMS, Merck with positive I/O lung cancer PhIII data - Roche’s Genentech ($RHHBY) has rolled out positive Phase III data for its cornerstone immunotherapy treatment Tecentriq in second-line non-small cell lung cancer (NSCLC)

Blood pressure drug may boost effectiveness of lung cancer treatment

Blood pressure drug may boost effectiveness of lung cancer treatment

The blood pressure drug ERLOTINIB can make treatment more effective in 10% to 30% of lung cancer patients.This early research conducted on mice and human cells in the laboratory was conducted by the Imperial College of London and Fudan University, was recently published in the scientific journal Cell...

Metformin Improves Benefit of Everolimus Plus Letrozole in Endometrial Cancer

Metformin Improves Benefit of Everolimus Plus Letrozole in Endometrial Cancer

Adding metformin to a combination everolimus plus letrozole regimen for women with advanced or recurrent endometrioid endometrial cancer (EEC) might offer clinical benefits, according to findings from an open-label phase II trial presented at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting, held June 3–7 in Chicago...

Hitting Melanoma with the One-Two Punch of Radiotherapy and an Oncolytic Virus

Hitting Melanoma with the One-Two Punch of Radiotherapy and an Oncolytic Virus

What is an Oncolytic Virus: An Oncolytic Virus is a type of virus that attacks, infects, and kills cancer cells. The cancer cells are killed by a process called Oncolysis which is the destruction of either neoplastic cells or tumors.